Hermetica Superfood Encyclopedia
The Short Answer
Wild Dagga contains the labdane diterpenoid marrubiin and the alkaloid leonurine, which exert bronchodilatory, anti-inflammatory, and mild cannabinoid receptor-modulating effects relevant to its primary use in Zulu respiratory medicine. Preclinical studies in rodent models demonstrate antidiabetic activity (reduced blood glucose and LDL, elevated HDL), anticonvulsant properties, and cardioprotective effects attributable to marrubiin and flavonoids, though no human clinical trial data with quantified effect sizes currently exist.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordwild dagga benefits
Wild Dagga — botanical close-up
Health Benefits
**Bronchodilation and Respiratory Relief**
Marrubiin relaxes bronchial smooth muscle and reduces airway inflammation, supporting the plant's traditional Zulu application for asthma, bronchitis, and persistent cough.
**Antidiabetic Activity**
In streptozotocin-induced diabetic rodent models, marrubiin and quercetin improved insulin sensitivity, reduced fasting blood glucose, and favorably shifted lipid profiles, suggesting potential adjunctive utility in metabolic dysregulation.
**Anticonvulsant Effects**
Aqueous and ethanolic leaf extracts demonstrated dose-dependent anticonvulsant activity in mouse seizure models, an effect attributed to marrubiin's modulation of neuronal excitability, consistent with the plant's traditional use for epilepsy.
**Cardioprotective and Antihypertensive Properties**
Marrubiin exhibits antiplatelet and anticoagulant activity while flavonoids including luteolin and apigenin contribute to vasodilatory effects, lending mechanistic plausibility to its traditional use for hypertension and circulatory support.
**Antioxidant and Hepatoprotective Activity**
Polyphenols including chlorogenic acid, ferulic acid, and luteolin-7-O-glucoside scavenge reactive oxygen species and attenuate hepatotoxin-induced liver damage in vitro, suggesting a hepatoprotective role at physiological concentrations.
**Analgesic and Mood-Modulating Effects**
Leonurine interacts with cannabinoid receptors to produce mild analgesia, anxiolysis, and a reported sense of relaxation and heightened sensory awareness, consistent with the traditional use of smoked preparations for headaches and neurological complaints.
**Antimicrobial Activity**
Ethanolic extracts show inhibitory activity against gram-positive and gram-negative bacteria in disk diffusion assays, supporting traditional topical use for infected wounds, skin boils, and dysentery.
Origin & History
Natural habitat
Leonotis leonurus is native to southern Africa, primarily South Africa, where it grows abundantly in grasslands, rocky hillsides, and forest margins from the Eastern Cape through KwaZulu-Natal and into Zimbabwe. Known colloquially as Lion's Tail or wilde dagga in Afrikaans, it thrives in well-drained soils under full sun at elevations up to approximately 1,800 meters. The plant is not typically cultivated commercially but is harvested from wild populations and increasingly grown in home gardens across southern Africa and as an ornamental in Mediterranean climates worldwide.
“Leonotis leonurus has been integral to Zulu, Xhosa, Sotho, and Khoi-San traditional medicine systems for centuries, where it is classified as a multipurpose medicinal plant used to treat the full spectrum of respiratory illness from mild coughs to tuberculosis, as well as snake and scorpion bites, epilepsy, and venereal disease. The plant's Afrikaans common name wilde dagga (wild cannabis) reflects historical and ongoing comparisons to Cannabis sativa based on the mild psychoactive properties of smoked preparations, though the two plants are botanically unrelated and pharmacologically distinct. Dutch and British colonial-era botanical surveys of the Cape documented its use by indigenous peoples as early as the 17th century, and it appears in foundational South African ethnobotanical compendia including Watt and Breyer-Brandwijk's Medicinal and Poisonous Plants of Southern and Eastern Africa (1962). In contemporary Southern African culture, the plant retains significance in rural traditional healing and is increasingly recognized internationally as a botanical curiosity due to its distinctive orange tubular flowers and its legal psychoactive reputation.”Traditional Medicine
Scientific Research
The evidence base for Leonotis leonurus consists exclusively of in vitro cell studies and small animal experiments; no published randomized controlled trials or prospective human clinical studies with quantified effect sizes have been identified as of the current review period. Key preclinical contributions include Ojewole (2005), who demonstrated antinociceptive, anti-inflammatory, and hypoglycemic effects of aqueous leaf extract in Wistar rats, and Mnonopi et al. (2011, 2012), who characterized marrubiin's cardioprotective and antidiabetic properties in streptozotocin-diabetic rodent models using histological, biochemical, and lipid panel endpoints. Antibacterial and hepatoprotective activities have been reported in multiple South African ethnopharmacology publications using agar dilution and carbon tetrachloride hepatotoxicity models, but minimum inhibitory concentrations and effective doses are inconsistently reported and not standardized to human-equivalent exposures. Overall, the scientific literature confirms biological plausibility for several traditional indications but cannot establish clinical efficacy, optimal dosing, or safety profiles in human populations without controlled trial data.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Internal)**
Leaves, flowers, and stems are simmered in water for 15–20 minutes to produce a tea consumed for respiratory complaints, hypertension, and diabetes; no validated human dose established, but traditional practitioners typically use one to two teaspoons of dried plant material per cup.
**Whole-Plant Infusion (Tea)**
Cold or hot water infusion of dried whole-plant material used in South African tradition for arthritis, piles, and general tonic purposes; frequency and volume are determined empirically by traditional healers.
**Smoked Preparation**
Dried leaves and flowers are rolled and smoked for neurological indications including epilepsy, headaches, and anxiety; leonurine content varies with plant part and drying method, and this route carries inhalation-related risks.
**Topical Poultice or Ointment**
Fresh or rehydrated leaves are applied directly to wounds, insect stings, eczema, and inflammatory skin lesions; no standardized formulation or concentration is commercially established.
**Ethanolic Extract (Experimental)**
50–400 mg/kg body weight in rodent studies for antibacterial and hepatoprotective assessments; human-equivalent doses have not been derived or validated
Used in laboratory research at concentrations of .
**Standardization**
No commercial supplement standardization to specific marrubiin, leonurine, or total polyphenol percentages is currently established or widely available.
Nutritional Profile
Leonotis leonurus is not consumed as a food and therefore lacks a conventional macronutrient or micronutrient profile. Its pharmacologically relevant phytochemical composition includes labdane diterpenoids dominated by marrubiin, present at qualitatively prominent levels in leaf and flower fractions though specific dry-weight concentrations have not been published in standardized assays. Flavonoid content includes luteolin, apigenin, quercetin, and luteolin-7-O-glucoside, with the glycoside form potentially offering improved aqueous solubility compared to aglycone forms, though intestinal deglycosylation by gut microbiota is required for absorption of the active aglycone. Phenolic acids including chlorogenic acid and ferulic acid contribute to total polyphenol content, which is enriched in standardized ethanolic extracts used experimentally. Essential oil fractions contain monoterpenoids and sesquiterpenoids at concentrations sufficient for aromatic detection but not pharmacologically characterized in isolation for human use.
How It Works
Mechanism of Action
Marrubiin, the dominant labdane diterpenoid, modulates calcium channel activity in smooth muscle cells to produce bronchodilatory and antihypertensive effects, while also inhibiting platelet aggregation through interference with thromboxane A2 pathways and enhancing peripheral insulin receptor sensitivity via PPAR-gamma-like mechanisms inferred from preclinical data. Leonurine acts as a partial agonist or modulator at CB1 and CB2 cannabinoid receptors, producing mild central nervous system depression, analgesia, and anxiolysis without the potency associated with delta-9-tetrahydrocannabinol. Flavonoids such as luteolin and apigenin inhibit pro-inflammatory cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, downregulate NF-κB signaling, and directly scavenge superoxide and hydroxyl radicals, contributing to the anti-inflammatory, neuroprotective, and hepatoprotective actions observed in cell culture models. Phenolic acids including chlorogenic and ferulic acid further support antioxidant defense via Nrf2 pathway activation and chelation of redox-active metal ions, though direct human in vivo confirmation of these molecular targets remains unavailable.
Clinical Evidence
No human clinical trials evaluating Leonotis leonurus for any indication have been published with reportable outcomes, effect sizes, or confidence intervals. The existing preclinical body of work provides proof-of-concept for antidiabetic, anticonvulsant, cardioprotective, antimicrobial, and analgesic activities but cannot be directly extrapolated to clinical efficacy in humans due to differences in metabolism, bioavailability, and dose scaling. Traditional use patterns across KwaZulu-Natal and the broader Southern African region offer centuries of observational safety and outcome data, but this evidence is anecdotal and subject to significant reporting bias. Researchers have called for standardized extract development, pharmacokinetic profiling, and phase I/II human safety trials before clinical recommendations can be made.
Safety & Interactions
Human safety data for Leonotis leonurus is sparse, with available information derived from anecdotal traditional use reports and limited animal toxicology rather than controlled clinical observation; no lethal dose, maximum tolerated dose, or NOAEL has been established for human consumption. Leonurine's mild cannabinoid receptor activity may produce dose-dependent psychoactive effects including euphoria, heightened sensory perception, and sedation, raising theoretical concerns about impaired cognition or motor function, particularly when smoked preparations are used; individuals operating machinery or with psychiatric histories should exercise caution. Potential pharmacokinetic drug interactions with anticoagulants (warfarin, aspirin), antidiabetic agents (metformin, insulin), and antihypertensives (ACE inhibitors, calcium channel blockers) are mechanistically plausible given marrubiin's antiplatelet, hypoglycemic, and vasodilatory activities, but no interaction studies have been conducted. The plant is contraindicated in pregnancy and lactation due to the absence of safety data, and use in pediatric populations, individuals with seizure disorders on pharmaceutical therapy, or those with hepatic compromise should be avoided pending formal toxicological assessment.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Leonotis leonurusWilde DaggaLion's TailLion's EarLebake (Sotho)
Frequently Asked Questions
What is wild dagga used for traditionally?
In Zulu and broader Southern African traditional medicine, wild dagga is used primarily for respiratory conditions including asthma, bronchitis, and tuberculosis-related coughs, as well as epilepsy, hypertension, diabetes, snakebite, arthritis, and infected skin wounds. Preparations range from water decoctions and teas taken internally to smoked leaves for neurological relief and topical poultices for skin conditions. These uses reflect centuries of ethnobotanical practice across Zulu, Xhosa, Sotho, and Khoi-San communities.
Does wild dagga get you high like cannabis?
Wild dagga produces mild psychoactive effects attributed to the alkaloid leonurine, which interacts with cannabinoid receptors to cause relaxation, mild euphoria, and heightened sensory perception, but it is pharmacologically and botanically unrelated to Cannabis sativa. The effects are substantially weaker than those of cannabis and are most pronounced when dried leaves and flowers are smoked. The common name 'wilde dagga' (Afrikaans for 'wild cannabis') reflects this perceived similarity rather than a true botanical or chemical relationship.
Is wild dagga safe to take as a supplement?
Comprehensive human safety data for Leonotis leonurus is lacking, so definitive safety conclusions cannot be drawn; the plant appears to be tolerated in moderate traditional use but has not been evaluated in clinical trials. Mechanistic concerns include potential interactions with anticoagulants, antidiabetics, and antihypertensives due to marrubiin's pharmacological activities, and mild CNS sedation from leonurine. Use during pregnancy and lactation, in children, or alongside pharmaceutical medications for the above conditions should be avoided until controlled safety studies are published.
What are the active compounds in wild dagga?
The primary bioactive constituents are marrubiin, a labdane diterpenoid responsible for bronchodilatory, antidiabetic, cardioprotective, and anticonvulsant effects, and leonurine, an alkaloid with mild cannabinoid receptor-modulating and analgesic properties. Supporting phytochemicals include flavonoids (luteolin, apigenin, quercetin, luteolin-7-O-glucoside) with antioxidant and anti-inflammatory activity, and phenolic acids (chlorogenic acid, ferulic acid) with antimicrobial and hepatoprotective roles. Essential oils containing monoterpenoids and sesquiterpenoids are also present, primarily in the aromatic flower fraction.
What is the correct dose of wild dagga?
No clinically validated or standardized supplemental dose for Leonotis leonurus has been established because no human pharmacokinetic or dose-ranging studies have been conducted. Traditional practitioners typically prepare infusions or decoctions using one to two teaspoons of dried leaf and flower material per cup of water, consumed once or twice daily for respiratory or systemic complaints. Smoked preparations have no measurable dose standard, and commercial extracts lack standardization to specific active compounds, making consistent dosing guidance impossible to provide at this time.
Does wild dagga interact with asthma or diabetes medications?
Wild dagga may potentiate the effects of bronchodilators and antidiabetic medications due to its marrubiin content, which independently relaxes airways and improves insulin sensitivity. If you are taking prescription asthma controllers, diabetes medications, or corticosteroids, consult your healthcare provider before adding wild dagga, as dose adjustments may be necessary. The combination could enhance therapeutic effects but also increase the risk of hypoglycemia or over-relaxation of airways.
Is wild dagga safe during pregnancy and breastfeeding?
Wild dagga safety during pregnancy and lactation has not been adequately studied in humans, and traditional use does not establish safety in these populations. The plant's active compounds, particularly marrubiin, have not been evaluated for teratogenic effects or transfer into breast milk. Pregnant and breastfeeding women should avoid wild dagga supplementation unless explicitly recommended by their healthcare provider.
What does the clinical research actually show about wild dagga's respiratory and metabolic benefits?
Most evidence for wild dagga's benefits comes from traditional use and preliminary animal studies, with limited human clinical trials. Rodent models demonstrate that marrubiin and quercetin improve insulin sensitivity and reduce fasting glucose, while the plant's bronchodilatory properties are supported by its traditional application and phytochemical profile, but human efficacy data remains sparse. High-quality randomized controlled trials in humans are needed to confirm dosage, efficacy, and safety for respiratory or metabolic conditions.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w wild-dagga-leonotis-leonurus curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
